Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients (TERI-PRO) ClinicalTrials.gov, 6 Feb 2015 Accessed on 13 Oct 2015 from https://www.clinicaltrials.gov/ct2/show/NCT01895335. CommentRecommendBookmarkWatch